Suppr超能文献

尿毒症中的醛固酮——超越血压。

Aldosterone in uremia - beyond blood pressure.

机构信息

Nierenzentrum, Ruperto Carola University Heidelberg, Heidelberg, Germany.

出版信息

Blood Purif. 2010;29(2):111-3. doi: 10.1159/000245635. Epub 2010 Jan 8.

Abstract

Aldosterone was in the past considered only as a prohypertensinogenic agent. It has recently become clear that apart from the classical endocrine action, i.e. causing blood pressure elevation as a result of salt retention, aldosterone has numerous blood-pressure-independent actions on nonepithelial tissue. Under conditions of high salt concentration, aldosterone is injurious to the kidney, heart and vasculature. Of particular interest are recent observations that aldosterone is a permissive factor for the effect of minor increases in plasma sodium concentration on endothelial cell dysfunction. Despite surprising effects of aldosterone blockade on blood pressure of anuric dialysis patients, the potential role of mineralocorticoid receptor blockade in dialysis patients is currently unclear and requires controlled investigation to define the risk of potential hazards, specifically hyperkalemia.

摘要

醛固酮过去仅被认为是一种促高血压生成剂。最近,人们清楚地认识到,除了经典的内分泌作用(即通过盐潴留导致血压升高)外,醛固酮对非上皮组织还有许多与血压无关的作用。在高盐浓度条件下,醛固酮对肾脏、心脏和血管有害。特别值得关注的是最近的观察结果,即醛固酮是允许血浆钠浓度轻微升高对内皮细胞功能障碍产生影响的一个因素。尽管醛固酮阻断对无尿透析患者血压的作用令人惊讶,但目前尚不清楚矿物质皮质激素受体阻断在透析患者中的潜在作用,需要进行对照研究来确定潜在危害的风险,特别是高钾血症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验